Thyrogen Related Published Studies
Well-designed clinical trials related to Thyrogen (Thyrotropin)
Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: A prospective controlled study. [2011.12]
Effects of physical activity on body composition and fatigue perception in patients on thyrotropin-suppressive therapy for differentiated thyroid carcinoma. [2011.07]
Low-normal or high-normal thyrotropin target levels during treatment of hypothyroidism: a prospective, comparative study. [2011.04]
Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial. [2010.10]
Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. [2010.08]
Does Postoperative Thyrotropin Suppression Therapy Truly Decrease Recurrence in Papillary Thyroid Carcinoma? A Randomized Controlled Trial. [2010.07.21]
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal. [2010.07]
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between recombinant human thyrotropin stimulation and prolonged levothyroxine withdrawal. [2009.09]
Effects of repeated whole-body cold exposures on serum concentrations of growth hormone, thyrotropin, prolactin and thyroid hormones in healthy women. [2009.06]
Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. [2007.09]
Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin. [2007.07]
Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects. [2007.01]
[Stimulation with 0,3 mg recombinant human thyrotropin (rhTSH) increases the effect of 131I therapy in patients with nontoxic nodular goiter. A prospective, randomized, double-blind trial--secondary publication] [2006.11.20]
Single-Dose Rexinoid Rapidly and Specifically Suppresses Serum Thyrotropin in Normal Subjectsa. [2006.10.24]
Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. [2006.07.24]
Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression. [2006.06]
Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial. [2006.04]
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. [2006.03]
Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study. [2005.12.29]
Acute hyperglycemia and activation of the beta-adrenergic system do not exhibit synergistic inhibitory actions on thyrotropin-releasing hormone (TRH)-induced thyroid stimulating hormone (TSH) secretion. [2005.02]
Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. [2005.01]
Serum thyrotropin-receptor autoantibodies levels after I therapy in Graves' patients: effect of pretreatment with methimazole evaluated by a prospective, randomized study. [2004.10]
Residues 34-39 in the thyrotropin receptor are not the target of autoantibodies from sera of patients with Graves' disease. [2004.08]
Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial. [2004.05]
Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. [2004.01]
Postpartum maternal hyperthyrotropinemia in an area in which iodine supplementation is required. [2003.10]
Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study. [2003.07]
Panic-related responses to pentagastrin, flumazenil, and thyrotropin-releasing hormone in healthy volunteers. [2003]
Recombinant thyrotropin for detection of recurrent thyroid cancer. [2002]
A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report. [2000.09]
Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients. [2000.08]
Thyrotropin-releasing hormone time-dependently influences thyrotropin microheterogeneity--an in vivo study in euthyroidism. [2000.07]
Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients. [2000.06]
Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts. [1999.12]
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. [1999.11]
Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. [1999.09]
The effects of endogenous opioids and cortisol on thyrotropin and prolactin secretion in patients with Addison's disease. [1999.05]
Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression. [1999.04.15]
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. [1999.04]
Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin-releasing hormone treatment. TRH Collaborative Trial Participants. [1998.11]
Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone. [1998.09]
Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group. [1998.02.19]
Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. [1998.02]
Effects of thyrotropin-releasing hormone on the sleep EEG and nocturnal hormone secretion in male volunteers. [1998]
Effects of cholinergic blockade on nocturnal thyrotropin and growth hormone (GH) secretion in type I diabetes mellitus: further evidence supporting somatostatin's involvement in GH suppression. [1997.11]
Effect of antenatal thyrotropin-releasing hormone on uterine contractility, blood pressure, and maternal heart rate. [1997.08]
Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. [1997.08]
Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat. [1997.06]
Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. [1997.03]
Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: adverse effects at 12-month follow-up. ACTOBAT Study Group. [1997.03]
Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics. [1997.02.01]
Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume. [1997.01]
Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. [1996.09]
Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man. [1996.07]
Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations. [1996.04]
Effects of thyrotropin-releasing hormone administration on the electroconvulsive therapy induced prolactin responses and seizure time. [1996.03.15]
[Concentration of thyroxine, triiodothyronine and thyrotropin in blood serum of children with goitre living in the region of Debica] [1996]
Temporal link between plasma thyrotropin levels and electroencephalographic activity in man. [1995.11.17]
The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers. [1995.09]
Thyrotropin-releasing hormone: does two hundred micrograms provide effective stimulation to the preterm fetal pituitary gland compared with four hundred micrograms? [1995.09]
Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries. [1995.06]
Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. [1995.04]
Effects of intravenous thyrotropin-releasing hormone on urethral closure pressure in females with voiding dysfunction. [1995]
A randomized, controlled trial of antepartum thyrotropin-releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. [1994.07]
Effects of administration of a low dose of frozen thyrotropin on serum total thyroxine concentrations in clinically normal dogs. [1994.06]
Scopolamine effects on the pressor response to thyrotropin-releasing hormone in humans. [1994]
Low-dose thyrotropin-releasing hormone effects in cognitively impaired alcoholics. [1993.08]
Short-lasting behavioural effects of thyrotropin-releasing hormone in depressed women: results of placebo-controlled study. [1993]
Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone. [1992.12]
Effects of thyrotropin-releasing hormone on regional cerebral blood flow in man. [1992.03]
Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. TRH Study Group. [1992.02.29]
Behavioral and endocrine interactions between thyrotropin-releasing hormone and ethanol in normal human subjects. [1991.12]
Thyrotropin receptor antibodies following treatment with recombinant alpha-interferon in patients with hepatitis. [1991.11]
The blunting of the thyrotropin response to repeated thyrotropin-releasing hormone administration is reduced by dopaminergic blockade both at normal and elevated serum levels of thyroid hormones. [1990.11]
Effect of acute hypercalcemia on thyrotropin (TSH) and triiodothyronine responses to TSH-releasing hormone in man. [1990.08]
Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus. [1990.04]
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patients. [1990.02]
Effects of the somatostatin analog BIM 23014 on the secretion of growth hormone, thyrotropin, and digestive peptides in normal men. [1989.02]
Fetal lung maturation: the combined use of corticosteroids and thyrotropin-releasing hormone. [1989.01]
Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease. [1989]
Effect of nifedipine on thyrotropin, prolactin, and thyroid hormone release in man: a placebo-controlled study. [1989]
Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man. [1988.06]
Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine. [1987.12]
Well-designed clinical trials possibly related to Thyrogen (Thyrotropin)
Treatment of iron-deficiency anemia in patients with subclinical hypothyroidism. [2013]
Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial. [2011.09]
Acute sleep deprivation reduces energy expenditure in healthy men. [2011.06]
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study. [2011.05]
Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. [2011.04]
Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. [2010.12.13]
Effect of recombinant human TSH on the uptake of radioactive iodine ((123)I) by the thyroid gland in healthy beagles. [2010.11]
Breast-milk iodine concentration declines over the first 6 mo postpartum in iodine-deficient women. [2010.10]
Improved in vitro fertilization outcomes after treatment of subclinical hypothyroidism in infertile women. [2010.09]
Comparative evaluation of two different dosage calculation protocols of iodine-131 in the treatment of hyperthyroidism. [2010.08]
A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. [2010.08]
Association between radioiodine therapy for Graves' hyperthyroidism and thyroid-associated ophthalmopathy. [2010.08]
Sodium nitroprusside infusion prevents hypothyroidism in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. [2010.08]
Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism. [2010.07]
Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. [2010.07]
Ghrelin affects the hypothalamus-pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. [2010.06]
Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial. [2010.06]
Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study. [2010.06]
|
